Else Nutrition (BABY) Q3 2024 earnings summary

Executive summary

• Achieved 5% year-over-year revenue growth in Q3 2024, reaching $1.8 million, despite limited marketing spend.

• Expanded retail presence with a pilot program at Costco and plans for distribution in over 900 new US grocery stores.

• Preparing to launch an Adult RTD product, with first commercial production scheduled for later in 2024.

• Implemented cost-saving measures to improve future margins and actively pursuing non-dilutive bridge funding and a long-term credit line.

Financial highlights

• Q3 2024 revenue increased to $1.8 million from $1.71 million in Q3 2023.

• Operating expenses for Q3 2024 were $3.6 million, up from $3.5 million in Q3 2023.

• Cash balance as of September 30, 2024, was $0.9 million, including restricted cash.

Outlook and guidance

• Anticipates expanded distribution through Costco in Canada and potentially the US.

• Expects product availability in over 900 additional US grocery stores upon finalizing a new retail partnership.

• Focused on ramping up marketing and optimizing capital structure to support long-term growth.